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Cyclin-dependent kinase subunit (CKS) proteins interact
with cyclin-dependent kinases (CDKs) with high affinity.
Mammalian CKS1 and CKS2 bind CDK1 and CDK2 and
partake in the control of cell cycle progression. We iden-
tified CKS-interacting proteins by affinity purification fol-
lowed by mass spectrometry in the human lymphocytic
cell line Ramos. Apart from known interactors, such as
CDKs, we identified a novel CDK-dependent interaction
between CKS proteins and the mitochondrial single-
stranded DNA-binding protein (mtSSB). mtSSB bound
both CKS1 and CKS2 and underwent CDK-dependent
phosphorylation. mtSSB is known to participate in repli-
cation of mitochondrial DNA. We demonstrated that mi-
tochondrial morphology and DNA integrity were compro-
mised in cells depleted of both CKS proteins or that had
inhibited CDK activity. These features are consistent with
the hypothesis of CKS-dependent regulation of mtSSB
function and support a direct role of cell cycle proteins in
controlling mitochondrial DNA replication. Molecular &
Cellular Proteomics 9:145–152, 2010.
CKS1 proteins are binding partners of cyclin-dependent
kinases (CDKs) and their activating cyclins. CKS proteins
covalently linked to Sepharose beads have been used histor-
ically as a reagent to purify active CDK complexes and to help
identify CDK-dependent substrates (1).
CKS proteins are evolutionarily conserved. In higher eu-
karyotes, there are two orthologues, CKS1 and CKS2. Human
CKS1 and CKS2 have been proposed as potential oncogenes
and biomarkers for cancer prognosis (2–8). Murine knock-
down of both CKS proteins results in lethality (9). Human
CKS1 has been demonstrated to be responsible for degrada-
tion of the cell cycle inhibitor p27kip by binding to the E3 ligase
complex SCFSKP2 (10). This governs the entry of cells into S
phase. Such function is unique to human CKS1 as human
CKS2, which is 81% identical in amino acid sequence, cannot
substitute for this function.
Cks1 in yeast has been shown to participate in the regulation
of transcription of a subset of genes. This evolutionarily con-
served function is also observed in mammalian cells (9, 11). This
could potentially explain the lethal phenotype observed when
both copies of Cks genes are deleted in mammalian cells.
In an effort to identify potential binding partners to CKS
proteins apart from CDKs, we applied CKS-coupled Sepha-
rose beads to mammalian total cell extracts and subjected the
eluates to mass spectrometry for identification of proteins.
Interestingly, we identified specific binding of both CKS1 and
CKS2 to the mitochondrial single-stranded DNA-binding pro-
tein (mtSSB).
Single-stranded DNA-binding proteins are evolutionarily
conserved, bind selectively to single-stranded DNA, and en-
able DNA replication (12). mtSSBs are small proteins (molec-
ular mass range from 13 to 16 kDa) that adopt a homotet-
rameric structure (13). mtSSB has a stimulatory role on the
rate of DNA unwinding by the mitochondrial TWINKLE heli-
case (14) and plays an important role in enhancing replication
and repair of mitochondrial DNA.
Mitochondria control cellular energy metabolism and are
also essential in vital biological pathways such as apoptosis.
Mitochondrial DNA accumulates somatic mutations during
aging and pathogenic processes such as cancer and diabetes
(15). Mitochondrial DNA copy number is usually maintained
during cell division, although it is not clear whether any uni-
fying mechanism regulates this process. It is also uncertain
how mtDNA replication is related to the cell cycle despite
evidence of certain signaling factors such as RAS, which was
reported to signal mitochondrial replication in G1 (16).
This study provides a proteomics analysis of the CKS pro-
tein complex in Ramos cells. mtSSB was thereby identified as
a novel interactor protein of CKS1 and CKS2. Given that CKS
proteins and CDKs are key drivers of the cell cycle, we also
aimed to examine whether CKS-CDK protein complexes have
direct roles in regulating mtSSB function.
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EXPERIMENTAL PROCEDURES
Recombinant Protein Production and Purification—Full-length
CKS1, CKS2, CKS1E63Q, CKS2E63Q, and CDK1 were cloned into
the pET-22HT vector (Novagen). Recombinant protein was purified
from bacterial lysates by nickel-chelating affinity chromatography
(nickel-nitrilotriacetic acid, Qiagen, Crawley, UK) followed by size
exclusion chromatography with the AKTAexplorer system on a Hi-
Load 16/60 Superdex 75 prep grade column (GE Healthcare). Bovine
serum albumin (96%) was purchased from Sigma and additionally
purified by use of the HiLoad 16/60 Superdex 75 prep grade column.
Purified recombinant proteins were covalently immobilized on beads
by the use of N-hydroxysuccinimidyl-Sepharose 4 Fast Flow (N-
hydroxysuccinimidyl-Sepharose, Sigma-Aldrich). Unreacted sites
were blocked with 1 M ethanolamine, pH 8.0. Measuring of coupling
efficiency was done as described by the GE Biosciences N-hydroxy-
succinimidyl-Sepharose manual. Briefly, coupling solution was acid-
ified to pH 2.5 by use of 2 M glycine-HCl, pH 2.0, and the absorbance
was measured at 280 nm.
Binding Experiments—CKS1, CKS2, CKS1E63Q, CKS2E63Q, and
CDK1 were attached to Sepharose beads as explained above and
incubated at room temperature for 1 h in a solution of recombinant
human mtSSB at a concentration of 50 g/ml in PBS supplemented
with 1% BSA. After three washes with 10 ml of PBS with or without
increasing salt stringency washes (to final NaCl concentrations of
150, 300, and 500 mM), proteins were eluted with SDS sample buffer
and applied to SDS-PAGE and Western blotting using an anti-mtSSB
antibody (Abcam, Cambridge, MA; catalog number Ab26205-50).
Pulldown Experiments—Purified recombinant CKS proteins were
covalently immobilized on beads by use of N-hydroxysuccinimidyl-
Sepharose 4 Fast Flow (Sigma-Aldrich) as described above. Ramos
cells (1.5  109 per sample) were lysed by slow rotation for 15 min in
10 ml of hypotonic buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 2 mM
EDTA, 0.3 mM sodium vanadate, 5 mM sodium pyrophosphate, 5 mM
sodium fluoride, 5 mM MgCl2, 1 mM DTT, complete protease inhibitors
(Roche Applied Science), and ATP regeneration system (2.4 mM ATP,
100 mg/ml creatine phosphokinase, and 10 mM creatine phosphate)
per sample. Nuclei were pelleted at 300  g for 10 min. Nuclear
proteins were extracted with 4 volumes of high salt buffer B (20 mM
HEPES, pH 7.9, 0.65 M NaCl, 1 mM EDTA, and 10% glycerol together
with all other additives as in buffer A) by rotation for 2 h at 4 °C.
Cytoplasmic and nuclear fractions were combined in a 4:1 ratio,
resulting in final salt concentration of 150 mM. The lysate was then
spun three times at 16,000  g. 100 l of protein-coated Sepharose
per sample was mixed with the cellular lysate and incubated overnight
at 4 °C under slow rotation. Sepharose beads were washed three
times with 12 ml of buffer identical in composition to the final lysis
buffer.
Bound proteins were eluted with 7 M urea, 2 M thiourea, and 4%
CHAPS solution. Eluate was extracted by methanol and chloroform
and precipitated by methanol. Briefly, 600 ml of methanol, 150 ml of
chloroform, and 450 ml of water were added to 200 ml of eluate and
spun at 16,000  g for 1 min. The upper aqueous layer was dis-
carded, and the protein partitioned at the interphase was precipitated
by the addition of 450 l of methanol. After a 2-min spin at 16,000 
g, pellets were dissolved in 6 M urea, reduced, alkylated, and digested
by sequencing grade modified trypsin (Promega, Southampton, UK)
overnight at 37 °C. Tryptic peptides were desalted by use of Sep-Pak
C18 cartridges (Waters) and analyzed by LC-MS/MS. A fraction of the
protein pellets was analyzed by two-dimensional electrophoresis as
described previously in detail (39). Briefly, proteins from all fractions
TABLE I
Proteins identified by use of baits attached to Sepharose beads
CKS1, CKS2, CKS1E63Q, and CKS2E63Q were attached to Sepharose beads and used as baits. BSA coupled to the beads was used as
control. Interactor proteins were pulled down from lysates of Ramos cells and identified by use of LC-MS/MS. Proteins binding to control beads
were subtracted from identified proteins binding to baits. Only proteins identified in three of four biological replicates are listed for CKS1 and
CKS2. Proteins identified in two out of four experiments for CKS1E63Q and CKS2E63Q are not shown. LDH, lactate dehydrogenase.
Bait proteins NCBI accession number Expectation value (protein) SEQUEST score Sequence coverage Unique peptides
%
CKS1
CDK1 gi16306492 1.4e14 230 70 16
CDK2 gi1942626 1.0e10 146 53 13
Cyclin A gi4502611 6.2e13 40 13 4
Cyclin B1 gi14327896 1.2e12 50 16 4
Cyclin B2 gi4757930 1.8e7 50 14 9
mtSSB gi4507231 4.8e10 30 26 3
HSP90 gi20149594 1.4e11 20 11 6
CDC37 gi5901922 9.2e8 20 7 2
SKP2 gi16306595 6.8e13 70 28 7
SKP1A gi25777713 1.9e12 20 18 2
Cullin 1 gi32307161 9.2e8 110 18 10
LDH, H chain gi13786847 5.2e5 20 22 2
CKS2
CDK1 gi16306492 2.1e14 200 75 15
CDK2 gi1942626 6.9e12 106 47 10
Cyclin A gi4502611 9.0e11 30 10 3
Cyclin B1 gi14327896 5.4e11 80 30 8
Cyclin B2 gi4757930 1.2e13 30 11 3
mtSSB gi4507231 5.7e8 20 17 2
HSP90 gi20149594 1.4e11 20 4 2
CDC37 gi5901922 8.3e8 20 8 2
LDH, H chain gi13786847 2.0e11 30 26 3
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were solubilized in IEF buffer (7 M urea, 2 M thiourea, 65 mM DTT, 2%
ASB-14, and 4% CHAPS) and separated according to their isoelectric
point using immobilized pH gradient strips (pH 3–10) 7 cm in length
(GE Healthcare). The proteins were then additionally separated by
SDS-PAGE and visualized by silver staining.
LC-MS/MS—LC-MS/MS analysis was performed on an LTQ-Orbi-
trap (Thermo Fisher Scientific) equipped with a SURVEYOR pump
and Thermo autosampler. Peptides were resolved using a fused silica
C18 capillary column (Nikkyo Technos Co.) with an initial desalting
step using a Michrom C18 Captrap. Liquid chromatography was car-
ried out at ambient temperature at a flow of 50 l/min using a gradient
of 0.1% formic acid in water (solvent A) and 0.1% formic acid in
acetonitrile (solvent B). Full profile data were acquired on the LTQ-
Orbitrap. The tune parameters were as follows: spray voltage, 1.40
kV; capillary temperature, 200 °C. A full scan was collected for eluted
peptides in the range of 400–1600 amu with the Orbitrap portion of
the instrument at a resolution of 60,000 followed by MS/MS using CID
with a dynamic exclusion of 40 s and a maximum number in the
dynamic exclusion list of 500 in the LTQ portion of the instrument with
a minimum count threshold of 500. An activation q value of 0.25 and
activation time of 30 ms were applied for MS2 acquisitions.
The RAW files were analyzed with Bioworks 3.3.1 (Thermo Electron
Corp.) as the peak list-generating software using default parameters.
The SEQUEST search engine was subsequently used to search
against the NCBInr database using the following settings: Homo
sapiens species restriction (justification: our cell line was of human
origin), number of protein entries searched, 218,357; number of
missed cleavages permitted, 2; precursor ion mass tolerance, 10
ppm; fragment ion mass tolerance, 0.8 Da; fixed modification, carb-
amidomethyl (residue specificity, cysteine); variable modification, ox-
idation (residue specificity, methionine); enzyme specificity, trypsin.
The search results were subsequently filtered using a CN of 0.1;
XCorr versus charge state of 1.5, 2.0, 2.5, and 3.0; cutoff expectation
values: default peptide probability, 0.001; default protein probability,
0.001; and number of distinct peptides, 2. Other parameters were at
default settings. The result was subsequently run through X! Tandem
software embedded within SCAFFOLD 2.1.03 software, and results
were validated.
Two-dimensional Electrophoresis—Two-dimensional electrophore-
sis was performed as described previously in detail (39). Briefly,
proteins from all fractions were solubilized in IEF buffer (7 M urea, 2 M
thiourea, 65 mM DTT, and 4% CHAPS) and separated according to
their isoelectric point using immobilized pH gradient strips (pH 3–10)
7–13 cm in length (GE Healthcare). The proteins were then addition-
ally separated by SDS-PAGE and visualized by silver staining.
MALDI-TOF MS—Protein spots were excised from the gel and
processed automatically by Progest (Genomic Solutions, Hunting-
don, UK). Briefly, gel pieces were soaked in 50 mM NH4HCO3, dehy-
FIG. 1. mtSSB binds CKS1 directly. A, binding of proteins to the Sepharose beads. The coupling efficiency was determined spectropho-
tometrically at 280 nm after the pH of protein solutions was adjusted to 2.5. The amount of protein bound to beads was calculated by
subtracting the total protein amount in solution before and after the coupling process, taking into account the wet volume of beads used for
coupling. The average amount of bound protein was 938  58 mg/ml of beads. Bar chart shows the mean  standard error of 4 independent
experiments. B, recombinant CKS1, CKS1E63Q, and CDK1 were bound to Sepharose beads and used as baits for mtSSB in solution (50
g/ml). Relative amounts of mtSSB in eluates were assessed by use of the mtSSB antibody and Western blotting. CKS1 binds mtSSB
efficiently but not CKS1E63Q or CDK1. C, the experiment in B was repeated with more stringent salt washes. CKS1 binding to mtSSB was
stable up to a final salt concentration of 300 mM. CKS1E63Q beads washed with PBS only were added as a negative control (right lane).
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drated with acetonitrile, then reduced by 10 mM DTT, and alkylated
with 100 mM iodoacetamide. Dried gel pieces were rehydrated with 3
l of a 30 ng/l solution of sequencing grade porcine trypsin (Pro-
mega) in 50 mM NH4HCO3 buffer for 15 min. An additional 9 l of 50
mM NH4HCO3 was added thereafter, and digestion was carried out at
30 °C overnight. Tryptic digests (0.7 l) were applied to the target
plate and allowed to air dry, and then 0.7 l of a saturated solution of
-cyano-4-hydroxycinnamic acid in 33% acetonitrile and 0.1% TFA
(v/v) was overlaid.
Mass spectra of the tryptic digests were obtained on an Autoflex
MALDI-TOF mass spectrometer (Bruker Daltonics, Billerica, MA). Ex-
ternal calibration was done with a mixture of seven standard peptides
by use of the FLEXControl Version 1.1.62.0 peak list-generating soft-
ware with default parameters. Spectra were analyzed by use of the
peak picking Bruker DataAnalysis for TOF 1.6g software. Internal
calibration was carried out by use of trypsin autolysis peaks. Mo-
noisotopic peptide masses of clearly defined peaks over the intensity
threshold of at least three times the base line were assigned manually,
trypsin autolysis and keratin peaks were excluded, and the mass lists
were used for protein identification in the NCBInr 20090123 nonredun-
dant protein database by Mascot 2.0 search engine (Matrix Science
Inc., London, UK) using the following settings: fixed modification, car-
bamidomethyl; variable modification, oxidation (Met); taxonomy, re-
stricted to H. sapiens, number of protein entries searched, 218,357;
enzyme specificity, trypsin. The mass accuracy of our analysis was set
at 70 ppm, and up to one missed cleavage was allowed. The following
acceptance criteria were used: a Mascot score above the cutoff score
of 76 (considered significant; over 95% probability that the result is not
false positive) and at least four matching masses.
Cks1 and Cks2 Knockdown in Immortalized Murine Embryonal
Fibroblasts (MEFs)—Two shRNAs against Cks1 (17) were cloned into
pRETRO SUPER, and the constructs were verified by sequencing.
Recombinant retroviruses encoding shRNA against Cks1 or a control
sequence were produced in 293T cells by transient transfection. The
viruses were used to infect wild-type or Cks2 knock-out immortalized
MEFs, three rounds of infections were carried out over 24 h, and after
another day, the cells were selected with puromycin at 1 g/ml for 3
days after which the knockdown was verified by quantitative RT-PCR.
Analysis of Mitochondrial DNA Content—Quantification of mito-
chondrial DNA content by quantitative PCR and analysis of mitochon-
drial DNA morphology were carried out according to published work
(18, 19).
Phosphoprotein Enrichment and Immunoblotting—The mitochon-
drial fraction (20) of Ramos cells or MEFs was enriched for phospho-
proteins by use of the Talon PMAC (phosphate metal affinity chro-
matography) phosphoprotein enrichment kit (Clontech) as instructed
by the manufacturer. Proteins in the eluted phosphoprotein and flow-
through fractions were concentrated by use of methanol precipitation
as described above, and 40 g of protein was then loaded into each
lane of an SDS-PAGE gel. Chicken polyclonal antibody to mtSSB
came from Abcam, rabbit polyclonal antibody to HSP90 was from
New England Biolabs (Hitchin, UK), and rabbit anti-tubulin antibody
was obtained from Sigma-Aldrich. Immunoblotting was carried out
according to standard protocols.
RESULTS
Identification of CKS-interacting Proteins—CKS proteins
covalently coupled to Sepharose beads have been used as a
tool to purify active CDKs from eukaryotes and plants (21). We
FIG. 2. mtSSB protein and mRNA levels in Cks1/Cks2-silenced
cells. A, protein levels of mtSSB as determined by immunoblotting.
Tubulin staining was used as a loading control. B, mtSSB mRNA levels
by quantitative RT-PCR. The experiments shown are representative of
the three performed. The results show the mean  S.E. of four inde-
pendent experiments.
FIG. 3. Mitochondrial DNA replication is dependent on func-
tional CKS-CDK complex. The relative content of mitochondrial
versus nuclear DNA was determined by quantitative RT-PCR. Relative
mtDNA content in wild type (wt) MEFs in comparison with Cks knock-
down MEFs. Results are expressed as mean values  S.E. of the
representative experiment from the three performed. Statistically sig-
nificant differences were determined by analysis of variance: *, p 
0.05.
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coupled human CKS1 or CKS2 to Sepharose beads and used
these as affinity matrix to pull down CKS-interacting proteins
from Ramos cells. This cell line was chosen because it ex-
pressed high endogenous levels of CKS1 and CKS2 (data not
shown).
Table I shows our results following affinity purification and
analysis by LC-MS/MS. These results were also confirmed
using two-dimensional electrophoresis (supplemental Fig. S1).
In agreement with published work (22, 23), CKS1 and CKS2
co-purified with CDK1, CDK2, and their respective activating
cyclins, cyclin B and cyclin A (Table I). Furthermore, the Skp2
complex (which comprises CUL-1, SKP1, and SKP2), which is
known to interact only with CKS1, was identified here in the
CKS1 sample but not in CKS2 (10). This validates the speci-
ficity and sensitivity of our method. Additional hits included
the mtSSB, lactate dehydrogenase H chain and the HSP90-
CDC37 chaperone complex (Table I). This study will only
focus on the biological significance of the CKS-mtSSB
interaction.
CKS Proteins Interact Specifically with mtSSB—We chose
to focus our study on the mtSSB as it has not previously been
reported to associate with CKS or CDK proteins. The interac-
tion of mtSSB with the CKS-CDK protein complex was further
confirmed by a binding assay using recombinant proteins
expressed in bacteria. Fig. 1 shows that recombinant mtSSB
bound directly to CKS1 (similar results were obtained for
CKS2; data not shown). Monomeric CDK1 and mutant CKS1
that harbors a point mutation in its loop that interacts with
CDK1, CKS1E63Q (24), had much reduced capacity to bind
purified mtSSB. In agreement with this, when a pulldown from
Ramos cell lysate was performed using CKS1E63Q and
CKS2E63Q coupled to Sepharose beads, binding to mtSSB
as well as CDKs was abrogated (data not shown). This sug-
gests that in vivo mtSSB only binds to CKS proteins that are
in complex with CDKs.
CKS-deficient Cells Have Compromised Mitochondria—
Because both CKS1 and CKS2 bound mtSSB, and it is known
that CKS1 and CKS2 play redundant roles in the maintenance
of cell viability (9), we decided to test mitochondrial integrity in
cells deficient in both CKS1 and CKS2 proteins. CKS proteins
have been shown to regulate transcription of a subset of
proteins (25). Expression of mtSSB is strictly regulated, and
mtDNA content is directly proportional to the abundance of
mtSSB mRNA (26). We examined both the protein levels and
FIG. 4. Knockdown of Cks1/2 leads to increased fragmentation of mitochondria. A, mitochondrial morphology was observed under a
fluorescence microscope using a 60 objective. Mitochondria were classified according to their morphology as Class 1 (fragmented
mitochondria), Class 2 (mixed), or Class 3 (tubular mitochondria). B, the number of cells with the indicated mitochondrial morphology is shown
as a percentage of the total number counted (minimum, 200). The results show the mean  S.E. of four independent experiments. *, p  0.05.
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expression of mtSSB mRNA to determine whether Cks knock-
down cells have reduced mtSSB (we refer to MEF cells with
Cks2 genetically knocked out and Cks1 knocked down by
shRNA as “Cks knockdown cells”). This was not the case (Fig.
2, A and B).
mtSSB ensures faithful replication of mitochondrial DNA
(27). Therefore, we performed a standard assay to measure
relative mitochondrial DNA content in control versus Cks
knockdown cells by quantitative PCR (19). Concomitant with
a reduced amount of mitochondrial DNA (Fig. 3), Cks knock-
down cells showed abnormal mitochondrial morphology with
increased fragmentation (Fig. 4). This is consistent with com-
promised mitochondrial DNA replication as reduced mito-
chondrial DNA has been linked to a more fragmented mor-
phology of mitochondria (28).
mtSSB Is Phosphorylated by CDK—Given that mtSSB
binding to CKS proteins is CDK-dependent, we tested
whether mtSSB is a substrate of CDK. We isolated mitochon-
dria from Ramos cells and applied a commercially available
phosphate metal affinity chromatography kit to enrich for phos-
phorylated proteins. mtSSBwas enriched in the phosphorylated
fraction. Phosphorylation is dependent on CKS binding as
MEFs deplete of CKS proteins did not phosphorylate mtSSB
(Fig. 5A). Roscovitine is a specific CDK inhibitor that displays
selectivity toward CDK1, CDK2, and CDK5 (29). Application of
roscovitine abrogated mtSSB phosphorylation and decreased
overall mtSSB expression (Fig. 5B). Incidentally, roscovitine was
able to inhibit mitochondrial DNA replication in a fashion similar
to that of the depletion of CKS proteins (Fig. 5C). These results
suggest that mtSSB undergoes CKS-CDK-dependent phos-
FIG. 5. mtSSB is phosphorylated by CDK1. Mitochondrial extracts were isolated from Ramos cells and applied to phosphoprotein
enrichment columns. Western blotting was carried out using mtSSB, HSP90, and tubulin antibodies. 40 g of protein was loaded in each lane.
Molecular weight markers are indicated on the left. The experiment shown is representative of the three performed. A, in wild-type Ramos cells
(left), all mtSSB was phosphorylated (found in the phosphorylated fraction). Knockdown of Cks genes by shRNA (right) abrogated the
phosphorylation (all mtSSBs were detected in the flow-through unphosphorylated fraction). HSP90, a protein found abundantly in mitochondria
that is known to be phosphorylated, acts as a “loading” control. B, Ramos cells were either treated or not treated with 20 M roscovitine for
16 h prior to lysis. Roscovitine inhibited expression of mtSSB and its phosphorylation. C, wild type MEFs were treated with increasing
concentrations of roscovitine for 16 h. The relative amount of mitochondrial versus nuclear DNA was determined by quantitative RT-PCR as
detailed in Fig. 3. *, p  0.05.
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phorylation in vivo and that inhibition of phosphorylation results
in defective replication of mitochondrial DNA.
DISCUSSION
Here we describe a direct interaction between CKS proteins
and mtSSB and reveal a previously unknown pathway
whereby cell cycle-regulating proteins modulate mitochon-
drial DNA replication. The lists of proteins pulled down by
CKS1 and CKS2 were similar with the only exception being
SKP2 and associated proteins Cullin and SKP1. These were
found only in complexes containing CKS1 and are in accord-
ance with published data (10, 30, 31). Apart from mtSSB, we
also identified specific CKS-mediated binding to lactate de-
hydrogenase H chain and the HSP90 complex. These hits are
currently subjects of further investigation. The absence of any
reproducible hits in the pulldowns with CKS1E63Q and
CKS2E63Q confirms that our assay is specific and that all the
hits identified were mediated by effective CDK binding.
mtSSB is a key component of the mitochondrial DNA rep-
lication machinery and is an essential gene in some organisms
(27, 32). To investigate whether the interaction between CKS
and mtSSB is functionally relevant, we tested whether Cks
knockdown cells exhibited a defect in mtDNA replication.
Based on the reduced mitochondrial DNA content and abnor-
mal mitochondrial morphology we observed in Cks knock-
down fibroblasts and what is known about the role of mtSSB
in mitochondrial DNA replication (33), we speculate that CKS
proteins are required for the efficient mtDNA replication through
the function of mtSSB. CDKs phosphorylate a number of pro-
teins involved in nuclear DNA replication (34, 35). However, their
involvement in replication of mitochondrial DNA has not yet
been reported. The ratio of mitochondrial to nuclear DNA is
maintained as cells divide, although how this takes place has
remained unclear. A number of studies have indicated that
mtDNA is mostly replicated in the pre-S phase and that mito-
chondrial morphology changes as the cell cycle progresses
(36). There is only one report so far suggesting that cell cycle
proteins can directly control mitochondrial processes (Taguchi
et al. report a CDK1-Cyclin B-dependent phosphorylation of the
mitochondrial protein Drp1 in mitosis).
In this study, we observed a significantly increased propor-
tion of fragmented mitochondria in Cks knockdown cells. This
may be due to the fact that mtDNA depletion leads to mito-
chondrial fragmentation (38). We have established that neither
the reduced mtDNA content nor changed mitochondrial mor-
phology in Cks knockdown cells was due to diminished
mtSSB mRNA expression or mtDNA protein levels. Post-
translational modifications of mtSSB have not been reported
so far. We postulate that the observed phosphorylation of
mtSSB is functionally significant because the addition of
roscovitine (which specifically inhibits CDK activity) resulted in
reduced levels of mitochondrial DNA, similar to the effect of
silencing of Cks genes from cells. In fact, Cks knockdown in
MEFs resulted in the abrogation of mtSSB phosphorylation.
This is consistent with a model of CKS-CDK-driven phosphor-
ylation of mtSSB.
We envisage a novel pathway whereby CKS-CDK-depend-
ent binding and phosphorylation of mtSSB directly impact its
ability to promote replication of mitochondrial DNA. Further
investigations are underway to determine the nature of this
phosphorylation, whether this fluctuates throughout the cell
cycle, and how this controls the function of mtSSB in in vitro
assays.
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